Skip to Main content Skip to Navigation
Journal articles

Déficit homozygote en antithrombine de type HBS ; à propos d'une famille

Abstract : Congenital antithrombin (AT) deficiency is the most thrombotic genetic abnormality of haemostasis. Total quantitative deficits are lethal as early as life intra-uterine. Only homozygous mutations concerning the heparin-binding site are compatible with life. We report here the case of an 18 years old patient with recurrent deep venous thrombosis of the inferior members. Haemostasis exploration shows a decreased AT activity (11%) in the presence of heparin while AT progressive activity and AT antigen are normal. Two other homozygous sisters are identified in this family study. Molecular study of AT gene show Arg47-Cys substitution, already reported in the literature with patients of different geographic origins. Treatment of patients with homozygous AT type HBS deficiency is similar that for patients with heterozygous AT deficiency; a continuous prophylactic anticoagulant treatment is always necessary and AT concentrates infusions are required in all situations needing curative heparin treatment.
Document type :
Journal articles
Complete list of metadatas

https://hal-riip.archives-ouvertes.fr/pasteur-01375249
Contributor : Institut Pasteur Tunis <>
Submitted on : Saturday, December 17, 2016 - 3:14:12 PM
Last modification on : Monday, October 8, 2018 - 5:44:08 PM

Identifiers

Collections

Citation

S Guermazi, H. Elloumi-Zghal, L Ben Hassine, S Romani, N. Khalfallah, et al.. Déficit homozygote en antithrombine de type HBS ; à propos d'une famille. Pathologie Biologie, Elsevier Masson, 2007, 55 (5), pp.256-61. ⟨10.1016/j.patbio.2006.10.006⟩. ⟨pasteur-01375249⟩

Share

Metrics

Record views

161